BlackRock Institutional Trust’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-610,716
| Closed | -$59.6M | – | 3999 |
|
|
2015
Q1 | $59.6M | Buy |
610,716
+29,735
| +5% | +$2.9M | 0.01% | 1218 |
|
|
2014
Q4 | $53.9M | Sell |
580,981
-12,228
| -2% | -$1.13M | 0.01% | 1246 |
|
|
2014
Q3 | $40.8M | Buy |
593,209
+3,084
| +0.5% | +$212K | 0.01% | 1391 |
|
|
2014
Q2 | $61.8M | Buy |
590,125
+7,816
| +1% | +$819K | 0.01% | 1181 |
|
|
2014
Q1 | $48.3M | Buy |
582,309
+33,516
| +6% | +$2.78M | 0.01% | 1302 |
|
|
2013
Q4 | $35.5M | Buy |
548,793
+130,177
| +31% | +$8.43M | 0.01% | 1512 |
|
|
2013
Q3 | $26.5M | Buy |
418,616
+24,031
| +6% | +$1.52M | 0.01% | 1647 |
|
|
2013
Q2 | $16.6M | Buy |
+394,585
| New | +$16.6M | ﹤0.01% | 1949 |
|